Recruiting

Observational Study

Sponsor:

UsAgainstAlzheimer's

Code:

NCT04466722

Conditions

Alzheimer Disease

Dementia

Mild Cognitive Impairment

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The main purpose of the Study is to develop an understanding over time and through multiple research projects, including surveys, interviews, online focus groups, and other primary research methodologies (A-LIST Research Projects) on what matters most to individuals concerned about brain health and those with and/or affected by Alzheimer's disease and other dementias, including caregivers.

Conditions

Alzheimer Disease

Dementia

Mild Cognitive Impairment

Study ID

NCT04466722

Start date

Aug 15, 2018

Status verified date

Jun, 2022

Completion date

Dec 31, 2023

Anticipated

Primary completion date

Dec 31, 2023

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

To be eligible to participate in the Study, an individual must meet all of the following criteria:

1. Age 18 years or older.
2. United States, Canada resident.
3. Self-report of cognitive difficulties, caregiver status or interest in brain health.
4. Have indicated willingness to participate by selecting "I Agree" option when joining the A-LIST. Additionally, will have clicked on link - invitation to take a specific survey
5. Able to speak, read, and understand English.

Exclusion Criteria:

An individual who meets any of the following criteria will be excluded from participation in this Study:

1. Unable to comply with the Study requirements.

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Phenotypical Characteristics of Patients and Caregivers [ Time Frame: 3 years ]

Central Contacts and Locations

Locations

UsAgainstAlzheimer's

Recruiting

Washington, District of Columbia, United States, 20043

Contacts

Principal Investigator:

Theresa Frangiosa, MBA

More Information

Sponsor

UsAgainstAlzheimer's

Last update posted

Jun 15, 2022

Last verified

Jun, 2022

Keywords

  • Alzheimer
  • Dementia
  • Cognitive
  • Cognition
  • Brain health

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by UsAgainstAlzheimer's on 2022-06-15.